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Abstract
Alcohol exposure triggers changes in gene expression and biological pathways in human brain. We explored
alterations in gene expression in the Pre-Frontal Cortex (PFC) of 65 alcoholics and 73 controls of European descent,
and identiﬁed 129 genes that showed altered expression (FDR < 0.05) in subjects with alcohol dependence.
Differentially expressed genes were enriched for pathways related to interferon signaling and Growth Arrest and DNA
Damage-inducible 45 (GADD45) signaling. A coexpression module (thistle2) identiﬁed by weighted gene coexpression network analysis (WGCNA) was signiﬁcantly correlated with alcohol dependence, alcohol consumption,
and AUDIT scores. Genes in the thistle2 module were enriched with genes related to calcium signaling pathways and
showed signiﬁcant downregulation of these pathways, as well as enrichment for biological processes related to
nicotine response and opioid signaling. A second module (brown4) showed signiﬁcant upregulation of pathways
related to immune signaling. Expression quantitative trait loci (eQTLs) for genes in the brown4 module were also
enriched for genetic associations with alcohol dependence and alcohol consumption in large genome-wide studies
included in the Psychiatric Genetic Consortium and the UK Biobank’s alcohol consumption dataset. By leveraging
multi-omics data, this transcriptome analysis has identiﬁed genes and biological pathways that could provide insight
for identifying therapeutic targets for alcohol dependence.

Introduction
Alcohol dependence (AD) can be deﬁned as a cluster of
physiological, behavioral, and cognitive phenomena in
which the use of alcohol takes a much higher priority for a
given individual than other behaviors that once had
greater value (American Psychiatric Association 1994)1.
The development of AD is characterized by frequent
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episodes of intoxication, preoccupation with alcohol, use
of alcohol despite adverse consequences, compulsion to
seek and consume alcohol, loss of control in limiting
alcohol intake, and emergence of a negative emotional
state in the absence of the drug (American Psychiatric
Association 1994)1. The changes in behavioral priorities
not only results in increased morbidity and mortality, it is
also a substantial social and economic burden on individual families and the nation2.
In individuals with alcohol dependence, there is a
complex interplay between genetic background, environmental factors, and history of alcohol exposure3. Alcohol
crosses the blood brain barrier and triggers changes in the
central nervous system4, including transcriptional
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changes in many different regions of the brain5–9. The
transcriptional effects of long-term alcohol consumption
are associated with pathways involved in the neuroimmune system, neurotoxicity, and changes in neuroplasticity6,7,9. Transcriptomes from complex tissues, such
as human brain, may be organized into networks of coexpressed genes that better reﬂect the biological functions
and organization of the tissue7–14. Application of bioinformatics techniques, such as weighted gene coexpression network analysis (WGCNA)15, has uncovered
networks associated with alcohol dependence8,9. However, past studies were performed on small numbers of
AD cases, thus limiting the statistical power to detect
small changes in alcohol-induced gene expression. In this
study, we utilized massively parallel sequencing of RNA
transcripts from postmortem human prefrontal cortex
(PFC) of 65 alcoholics and 73 controls of European descent to explore transcriptional networks and genetic
variation and identiﬁed groups of coexpressed genes
associated with alcohol dependence. Our analysis provides systems-level evidence of genetic networks within
the PFC that contribute to the pathophysiology of alcohol
drinking behavior in humans.
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(ThermoFisher Scientiﬁc). An Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) was used to test
the integrity of RNA samples. Samples with an RNA
integrity number (RIN) < 5.5 were removed from futher
analyses. Sixty samples were processed at the Waggoner
Center for Alcohol and Addiction Research (WCAAR),
The University of Texas at Austin while 83 samples were
processed at the Ronald M. Loeb Center for Alzheimer
disease, Icahn School of Medicine at Mount Sinai. Details
about the library preparation and sequencing is provided
in the supplementary document.
Mapping and quantiﬁcation of gene expression

Raw reads were aligned to human genome 19 (hg19)
using STAR aligner (version 2.5.3.a)16. We used QC tools
RSeQC (http://code.google.com/p/rseqc/) and Picard
(https://broadinstitute.github.io/picard/) to evaluate RNA
sequence quality including the %GC, %duplicates, gene
body coverage, unsupervised clustering, and the library
complexity. We used the Picard “MarkDuplicates” option
to ﬂag and remove duplicate reads. Gene quantiﬁcation
was performed with featureCounts (SUBREAD package;
release 1.6.0)17 using Gencode annotations (Release 19
(GRCh37.p13)).

Materials and methods
Case selection and postmortem tissue collection

Human autopsy brain samples were obtained from the
New South Wales Tissue Resource Centre at the University of Sydney (http://sydney.edu.au/medicine/
pathology/btrc/). Fresh frozen samples of the superior
frontal gyrus (Brodmann area 8; referred to as prefrontal
cortex (PFC) in this manuscript) were collected from each
postmortem sample. Brain tissue was sectioned at 3 mm
intervals in the coronal plane. Alcohol-dependent diagnoses were conﬁrmed by physician interviews, review of
hospital medical records, questionnaires to next-of-kin,
and from pathology, radiology, and neuropsychology
reports. Tissue samples were matched as closely as possible according to age, sex, post-mortem interval, pH of
tissue, disease classiﬁcation, and cause of death. To be
included as part of the alcohol-dependent cohort, subjects
had to meet the following criteria: greater than 18 years of
age, no head injury at time of death, lack of developmental
disorder, no recent cerebral stroke, no history of other
psychiatric or neurological disorders, no history of intravenous or polydrug abuse, negative screen for AIDS and
hepatitis B/C, post-mortem interval within 48 h, and
diagnosis of AD meeting the DSM-IV criteria1.
Sample preparation

The Qiagen RNeasy and Lipid Tissue kit (Qiagen,
Valencia, CA, USA) was used to extract total RNA from
human PFC brain tissue, and RNA concentration was
measured with a NanoDrop 8000 spectrophotometer

Selection of covariates to for analyses
Linear regression

We ﬁrst performed a linear regression with alcohol
dependence as a dependent variable to identify possible
covariates (e.g. sex, age, PMI). The mean age of AD
subjects was 55.65 years and was not signiﬁcantly different from the age of control subjects (54.96) (Table 1).
There was no signiﬁcant difference in distribution of RIN
and brain pH between cases and controls (Table 1).
Postmortem interval (PMI) was signiﬁcantly lower for the
alcohol-dependent subjects.
Variance partition analysis

We used the variancePartition package18 in R to calculate the proportion of variance in RNA expression
explained by known covariates such as age, gender, RIN
Table 1 Demographic proﬁle of alcohol-dependent and
control subjects
Trait
Male (%)

Alcohol Dependent (N = 65)
51 (78%)

Control (N = 73)
60 (82%)

Mean Age (SD) (yrs)

55.65 (11.81)

54.96 (12.11)

Mean PMI (SD) (hrs)

33.66 (15.59)*

26.63 (13.25)

Brain pH (SD)

6.54 (0.23)

6.58 (0.29)

RIN (SD)

6.84 (0.96)

7.0 (1.01)

*

P value = 0.0049
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and PMI, using the variancePartition package in R. The
variancePartition18 package uses linear mixed model
based statistical methods to quantify the contribution of
multiple sources of variation and identify the covariates
that required correction in the ﬁnal analysis. Supplementary ﬁgure 1A shows violin plots depicting drivers of
variation in gene expression data without accounting for
covariates. The ﬁgure shows that sequencing batch is a
major driver of variation in a large proportion of genes,
while RIN and sex have large effects on only a few genes.
We used the voom function in the Limma package
(https://www.bioconductor.org/packages/devel/bioc/
vignettes/limma/) to account for the effect of sequencing
batch, RIN, age, sex and PMI on gene expression. After
removing the effects of these covariates, alcohol-related
phenotypes explained the largest proportion of the
remaining variation in gene expression (Supplementry
Figure 1B).
Differential gene expression analysis

Gene-level analyses started with the featureCountsderived sample-by-gene read count matrix. The basic
normalization and adjustment pipeline for the expression
data matrix consisted of: (i) removal of low expression
genes (<1 CPM in > 50% of the individuals); (ii) differential gene expression analysis based upon adjustment for
the chosen covariates. We ﬁltered out all genes with lower
expression in a substantial fraction of the cohort, with
18,463 genes with at least 1 CPM in at least 50% of the
individuals; note that only these genes were carried forward in all subsequent analyses. The following design was
used for the ﬁnal differential expression analysis using the
DeSeq219 package as implimented in R: gene expression ~
DSM4 alcohol classiﬁcation + sex + age + PMI + RIN +
batch.
Pathway analyses of differential expression

Ingenuity® Pathway Analysis (IPA®) was used to perform pathway, canonical pathways, and causal network
analysis. All genes that passed the threshold of
signiﬁcance at 25% FDR were included in the analysis
Table 2.
Gene ontology analysis

Gene ontology analyses were performed using the
clusterProﬁler package20 as implemented in R. All differentially expressed genes that passed the threshold of
signiﬁcance at 25% FDR were included in the analysis.
Results for the enrichment analysis were extracted and
plotted using the ggplot2 package in R.
Gene co-expression analysis

Scale-free co-expression networks were constructed
using the weighted gene coexpression network analysis
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(WGCNA) package in R15. WGCNA provides a global
perspective, emphasizing the correlation between genes to
classify different molecular groupings, rather than focusing on individual genes. WGCNA deﬁnes modules using a
dynamic tree-cutting algorithm based on hierarchical
clustering of expression values (minimum module size =
100, cutting height = 0.99, deepSplit = TRUE). The networks were constructed at a soft power of 14 at which the
scale-free topology ﬁt index reached 0.90 (Supplementary
Figure 2B). We further merged modules that had similar
co-expression patterns by calculating the eigengenes and
merging those having a correlation > 75% (Supplementary
Figure 2C). Correlation of module eigengenes with alcohol dependence, alcohol consumption, AUDIT scores and
number of years of drinking (module-trait correlation
analysis) was evaluated using Spearman’s rank correlation
analysis. We used the DSM4 criteria for alcohol dependence classiﬁcation as provided by the New South Wales
Tissue Resource Centre at the University of Sydney. For
each individual in the RNA-Seq dataset a module eigen
value was calculated for each module. This module eigen
value was used to perform the correlation analysis of the
traits (e.g. alcohol dependence, alcohol consumption and
Audit scores) with each whole module. Digital deconvolution showed no signiﬁcant differences in the percentage
of neurons, astrocytes and microglia in the PFC of alcoholics and controls (Supplementary Figure 3)21; therefore
we did not perform any correction for cell-type heterogeneity. Assigned modules were functionally annotated
against known molecular/functional categories and
pathways using Ingenuity Pathway Analysis (IPA).
GWAS enrichment analysis

The summary statistics from a GWAS of alcohol
dependence (PGC-AD) were provided by the Psychiatric
Genetics Consortium Substance Use Dependence working group22 (Walters et al.). Summary statistics for the
UKBB alcohol consumption (UKBB-AC) GWAS23 were
provided by Dr. Toni Clarke. We also downloaded the
summary statistics for Tobacco and Genetics (TAG)
Consortium’s GWAS24 of cigarettes per day from the
PGC website (https://www.med.unc.edu/pgc/results-anddownloads). SNPs from the PGC-AD and UKBB-AC
studies were mapped to PFC expression quantitative trait
loci (eQTLs) in 461 post-mortem brains from the Religious Orders Study and Memory and Aging Project (ROS/
MAP)25 (Bennett et al). Enrichment analysis was performed for SNPs meeting the criteria of eQTL P < 5 ×
10−8 in the ROSMAP dataset and tested for overrepresentation in GWAS of AD (PGC-AD), alcohol consumption (UKBB-AC) and TAG-CPD. Since there are a
few loci that passed the genome-wide signiﬁcance
threshold in alcohol and smoking GWAS analysis, we
tested the polygenicity of alcoholism and smoking by
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exploring the overenrichment in variants that passed
nominal threshold of signiﬁcance in these datasets. The
enrichment analysis was focused on eQTLs for the genes
within modules that were correlated with AD in the
module-trait correlation analysis. The two modules
(thistle and brown4) that showed signiﬁcant enrichment
(p ≤ 0.05) in the Fisher exact test were subjected to
100,000 permutations to report the ﬁnal P value of
enrichment. We also performed the gene-based analysis
by Multi-marker Analysis of GenoMic Annotation
(MAGMA)26 on summary statistics of PGC-AD, UKBBAC and TAG-CPD GWAS using Functional Mapping and
Annotation of GWAS (FUMA-GWAS)27. The summary
statistics of this gene-based analysis were overlaid on the
IPA networks to identify the genes in these networks that
also have nominal to moderate evidence of genetic
contributions.

that were part of this network were also nominally signiﬁcant (p < 0.05) in the PGC-AD and UKBB-AC GWAS
(Fig. 1d).
Identiﬁcation of gene co-expression networks and
modules

After correcting for the effects of batch, age, and RIN,
the hierarchical clustering of expression data from nearly
18,000 genes generated 27 different modules (Supplementary Figure 1). Trait-module correlation analyses
identiﬁed ﬁve modules that were signiﬁcantly correlated
to at least one alcohol-related trait (Fig. 2). Of these ﬁve
modules, the thistle2 module (containing 72 genes), was
negatively correlated with alcohol dependence and other
alcohol-related traits. The brown4 module (containing of
795 genes) was positively correlated with AD, AUDIT,
alcohol consumption and duration of alcohol use.

Results
Differential expression analysis

Thistle2 module

Analysis of PFC tissue derived from 65 alcoholics and
73 controls identiﬁed 827 differentially expressed genes at
25% FDR, 298 genes at 10% FDR and 129 genes at 5% FDR
(Fig. 1a, Supplemental Table 1; protein coding genes
only). Transient Receptor Potential Cation Channel Subfamily C Member 3 (TRPC3) was the top differentially
expressed gene with signiﬁcantly lower expression in
alcohol-dependent subjects (FC 0.82; p = 4.6 × 10−9),
while Kinesin Family Member 19 (KFM19) showed signiﬁcantly higher expression in alcohol-dependent subjects
(FC 1.24; p = 5.7 × 10−9). IPA analysis of the differentially
expressed genes (FDR < 25%) showed signiﬁcant enrichment for pathways involved in interferon signaling,
GADD45 signaling, and other immune-related pathways
(Fig. 1b). Gene-ontology enrichment analysis using clusteProﬁler mapped a large proportion of genes to biological processes involved in blood coagulation and ﬂuid
transport (Fig. 1c). The network analysis in IPA mapped
the signiﬁcant genes to networks involved in neurodegenerative disorders and organismal injury. Several genes

Pathway enrichment analysis of the thistle2 module
showed a signiﬁcant downregulation of pathways related
to calcium signaling (Fig. 3a). Gene-ontology enrichment
analysis using the clusterpProﬁler showed signiﬁcant
enrichment for biological processes involved in “response
to nicotine” and “excitatory postsynaptic potential” (Fig.
3b). Several genes in the thistle2 module that were signiﬁcantly downregulated in the PFC of alcohol-dependent
subjects. Differentially expressed genes in the thistle2
module mapped to networks involved in G-protein coupled receptor signaling, calcium signaling, and opioid
signaling (Fig. 3c). Cholinergic Receptor Nicotinic Alpha
subunits 6 and 2 (CHRNA6 UKBB-AC P = 7.60 × 10−3;
CHRNA2 PGC-AD P = 1.4 × 10−2), Meningioma 1 (MN1,
PGC-AD P = 9.1 × 10−3) and Hyaluronan And Proteoglycan Link Protein 1 (HAPLN1, UKBB-AC P = 1.9 ×
10−2) are some exmples where differntialy expressed
genes in thistle 2 module also showed some evidence of
genetic contribution towards alcohol consumption or
dependence.

Table 2 Results of GWAS enrichment analysis in modules correlated with alcohol dependence and alcohol consumption
RNA-Seq data (N = 138)

GWAS data

Module trait correlation

GWAS P 0.05, eQTL P < 5 × 10−8

ID

AD

P

Audit

P

AC

P

PGC-AD

UKBB-AC

TAG-CPD

Thistle2

−0.28

9.00E-04

−0.25

3.00E-03

−0.22

9.00E-03

1.50E-02a

1.30E-02a

5.52E-01a

Brown4

0.18

4.00E-02

0.14

1.00E-01

0.12

1.00E-01

4.20E-03b

2.28E-01b

4.81E-03b

AD alcohol dependence, Audit audit scores, AC alcohol consumption
a
Permuted P value for the left-tail Fisher’s exact test (under-enriched)
b
Permuted P value to test right-tail Fisher’s exact test (over-enriched)
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Fig. 1 Top genes, pathways and networks from differential gene expression in DLFPC region from 68 alcoholics and 70 controls. a Volcano
plot showing top differentially expressed genes among cases and controls. b The genes passing FDR threshold of 20% were inputted to IPA for
pathway enrichment analysis. The ﬁgure shows some of the top pathways identiﬁed by IPA. P values here are from right tail Fisher’s exact test. c
Enrichment analysis of gene ontology “biological process” terms. Color depicts the qvalues with red being the strongest evidence of enrichment. d
Network analysis on top genes (FDR < =20%) mapped to networks involved in the neurodegenerative disorders and organismal injuries. P value
under the gene is the uncorrected p value for differential expression among alcoholics and controls. The nominally signiﬁcant genes in the UKBB-alc
and PGC-SUD GWAS are highlighted with purple border and blue annotation

Brown4 module

Pathway analysis for differentially expressed genes in the
brown4 module showed signiﬁcant enrichment for
Growth Arrest and DNA Damage (GADD45) signaling
and for biological processes related to the inﬂammatory
response (Fig. 4). Other genes that were also signiﬁcantly
upregulated in the PFC of alcoholics mapped to networks
involved in infectious and respiratory diseases.
GWAS enrichment analysis

GWAS enrichment analysis of signiﬁcant eQTLs (P ≤
5 × 10−8) for all genes in the top 5 modules (ranked by P
value in module-trait correlation analysis), showed evidence of enrichment for SNPs associated with AD
(GWAS p ≤ 0.05) in PGC-AD and alcohol consumption in
UKBB-AC datasets (Table 2). The brown4 module was
also enriched for GWAS association in the TAG-CPD

dataset. The thistle2 module did not show enrichment of
GWAS association. Surprisingly, genes in the thistle2
modules were signiﬁcantly depleted for GWAS signals in
the PGC-AD and UKBB-AC GWAS analyses. This ﬁnding
was conﬁrmed by permutation analysis.

Discussion
To our knowledge, this is the largest transcriptome
analysis comparing PFC of alcohol-dependent cases and
controls. The present study identiﬁed 129 genes (FDR <
0.05) that were differentially expressed in alcoholdependent subjects (Supplementary table 1). FKBP5, a
well studied gene that is asoociated with alcohol use28–31,
showed increased expression in the PFC of alcoholdependent subjects in our differential gene expression
analysis (l2FC 0.27; P = 4.57 × 10−7). Other studies have
also shown that FKBP5 plays a role in alcohol drinking

Kapoor et al. Translational Psychiatry (2019)9:89
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Fig. 2 Trait module correlations with P values for the top 5 modules. WGCNA identiﬁed 27 modules, out of which 5 modules showed nominalmoderate statistical signiﬁcance with any of 4 alcohol-related trait (AUDIT, alcohol consumption (gms/day), duration of drinking (years), DSM4 AD
(classiﬁcation). Thistle2 module also passed the multiple test correction (27 modules, 4 traits; 0.05/31 = 1.6 × 10−3)

behaviors in rodents28,29 and humans32. FKBP5 encodes
FK506-binding protein 5, a glucocorticoid receptor (GR)binding protein implicated in various psychiatric disorders and alcohol withdrawal severity30. Qiu and colleagues30 reported that Fkbp5 KO mice exhibited
increased alcohol consumption compared with wild-type
mice. Another study has shown that the absence of Fkbp5
enhances sensitivity to alcohol withdrawal in mice33.
Recent ﬁndings also suggested that Fkbp5 expression in
mesocorticolimbic dopaminergic regions is associated
with early life-stress mediated sensitivity to alcohol
drinking and that there is a gene–environment interaction
among FKBP5 genotype and parent–child relationship
that inﬂuences alcohol drinking.
Genes showing signiﬁcant differences in expression
between alcohol-dependent subjects and controls were
enriched in pathways related to interferon and
GADD45 signaling (Fig. 1b). Interferons are cytokines
that
have
antiviral,
antiproliferative,
and

immunomodulatory effects and the interferon pathway
plays a critical role in human innate and adaptive immune
responses34. Our pathway analysis results are consistent
with earlier ﬁndings showing induction of innate immune
genes by stress and drug abuse35. Furthermore, mRNA
expression studies in human brain showed signiﬁcant
changes in expression of genes related to immune or
inﬂammatory responses in hippocampus7 and nucleus
accumbens8. The neuroinﬂammation associated with
chronic alcohol exposure and withdrawal may be attributed to microglial activation and is associated with the
neuropathology of chronic alcohol exposure36. Differentially expressed genes (FDR < 25%) also mapped to networks associated with neurodegenerative disorders and
organismal injury (Fig. 1d). Many differentially expressed
genes in this network are involved in nervous system
development and function. Speciﬁcally TRPC3 and calcium dependent protein kinase 4 (CAMK4) are involved
in excitatory post-synaptic current while Ampa receptor,

Kapoor et al. Translational Psychiatry (2019)9:89
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Fig. 3 Enrichment analysis of genes in thistle2 module that are differentially expressed in alcoholics and controls. a More than 50% of genes
in calcium signaling pathways were found to be downregulated in the thistle2 module. b Enrichment analysis for GO:BP terms showed
downregulation of genes related to response to nicotine and postsynaptic potential. c Nearly 15 genes mapped to network related to amino-acid
metabolism with many genes that were involved in G-protein coupled receptor signaling, calcium signaling and opioid signaling pathway. The
nominally signiﬁcant genes in the UKBB-alc and PGC-SUD GWAS are marked with red boundaries (ADCY5 P = 7.07 × 10−7 in UKBB-AC, ADCY7, P =
2.2 × 10−4 in UKBB-AC), IL12B, P = 1.1 × 10−2 in PGC-AD, PIK3C2G, P = 6.8 × 10−3 in UKBB-AC, PIK3R4, P = 3.4 × 10−2 in PGC-AD, CHRNA6 in UKBB-AC P
= 7.60 × 10−3, CHRNA2 in PGC-AD P = 1.4 × 10−2, MN1 in PGC-AD P = 9.1 × 10−3 and HAPLN1 in UKBB-AC P = 1.9 × 10−2)

Glutamate Ionotropic receptor AMPA type subunit 4
(GRIA4), Calcium dependent protein kinase ii (CaMKII)
and CAMK4 are involved in synaptic transmission.
Although we identiﬁed several genes that were differentially expressed in the PFC of alcohol-dependent

subjects, the variance explained by individual genes was
very small (0.15–1%). The differential expression observed
here is smaller than that reported in earlier differential
expression studies of alcoholism, but it is consistent with
differential expression studies of larger sample size37. For

Kapoor et al. Translational Psychiatry (2019)9:89
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Fig. 4 Enrichment analysis of brown4 module genes that were differentially expressed (FDR* < 0.05) among alcoholics and controls. a
Pathway analysis showed signiﬁcant upregulation of genes related immune signaling and metabolism. b Enrichment analysis for GO:BP terms
showed enrichment of genes related to inﬂamatory response. c The genes in the brown4 module mapped to network involved in infectious and
respiratory diseases. The genes that were nominally signiﬁcant in the UKBB-Alc and PGC-SUD GWAS are highlighted with red boundaries

example, the CommonMind consortium reported similar
fold changes in the differential expression study of schizophrenia and they showed that their observation is
consistent with plausible models for average differential
gene expression and the polygenic inheritance of schizophrenia. The polygenicity of AD has also been observed
by the GWAS of alcoholism and other complex

behavioral/psychiatric disorders22,38–41, and it was
demonstrated that effect size for each individual genetic
variant is very small. Studies that used a co-expression
network approach also showed that alcohol dependence is
shaped, in part, by persistent alterations in networks of
co-expressed genes that collectively mediate excessive
drinking and other alcohol-dependent phenotypes8,9.

Kapoor et al. Translational Psychiatry (2019)9:89

These and other studies also demonstrated that the gene
network structure is signiﬁcantly correlated with lifetime
alcohol consumption in addition to an overall loss in
network structure; furthermore, the neurobiology of
alcohol dependence may be due to altered covariation of
gene modules, rather than discrete changes in differentially expressed genes across the transcriptome9,13.
Trait-module correlation analysis for the thistle2 module showed a signiﬁcant negative correlation with alcohol
dependence (−0.28, P = 9.0 × 10−4), alcohol consumption
(−0.22, P = 9.0 × 10−3), and AUDIT score (−0.25, P =
3.0 × 10−3), while the brown4 module showed a positive
correlation (0.18, P = 4.0 × 10−2) with alcohol dependence
(Fig. 2; Table 2). The salmon4 module was associated with
the total number of drinking years (−0.24, P = 4.0 ×
10−3), independent of the age of the subjects. Genes in the
thistle2 module were signiﬁcantly downregulated in the
PFC from alcoholics. Many genes in the thistle2 module
mapped to networks involved in opioid signaling and
nicotine response, highlighting the importance of this
module in addiction-related traits. Pathway analysis
showed that all genes that overlapped with genes involved
in calcium signaling were signiﬁcantly downregulated
(Fig. 3a). Acute ethanol exposure has been shown to
inhibit Ca2+ currents induced by PKC-dependent phosphorylation of mGluR5 in neurons42. Early studies in
PC12 cell cultures also showed that ethanol has a signiﬁcant inhibitory effect on the inﬂux of Ca2+ through Ltype voltage-gated Ca2+ channels43. Alcohol exposure
also modulates Ca2+ signaling between astrocytes and
neurons44 (Warden et al.), and Ca2+ acts as a second
messenger that controls multiple processes in immune
cells, including chemotaxis and secretion of pro- and antiinﬂammatory cytokines. Our analyses provide further
evidence that alcohol exposure alters Ca2+ signaling in
the brains of alcoholics and could potentially alter communication between neurons and brain immune cells.
Another module that correlated with alcohol dependence,
brown4, was also enriched in immune response and
infectious diseases, providing additional evidence for the
role of the neuroimmune system in the etiology of alcohol
dependence. Some of the differentially expressed genes in
this network were also statistical signiﬁcant in the genebased tests (RASD1, UKBB-AC, P = 1.64 × 10−5 and
ARID5A, UKBB-AC, P 1.4 × 10−3). The differentially
expressed FKBP5 gene was also part of the brown module,
but it was not identiﬁed as hub gene according to intramodular connectivity (supplementary table 2).
Enrichment analysis of nominally signiﬁcant GWAS
variants (p < 0.05) that were also eQTLs (p < 5 × 10−8) for
genes in the thistle2 module showed signiﬁcant under
enrichment in the two-tail Fisher test (Table 2). The
under-enrichment remained signiﬁcant even after 100,000
permutations. This might be due to the small size of this
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module (N = 72 genes). Although some of the differntialy
expressed genes were signiﬁcant in the gene-based tests
performed in UKBB-AC and PGC-AD datasets using
MAGMA (CHRNA6, CHRNA2, MN1 and HAPLN1). In
the calcium signaling network (Fig. 3c), a few genes that
were not part of the thistle2 module, but were essential to
create network connections, were also found to be signiﬁcant (3.4 × 10−2 ≤ P ≥ 4.8 × 10−2) in the gene-based
tests (circled in red; Fig. 4c). This suggests possible
gene–environment (alcohol exposure) interactions in the
etiology of alcohol dependence. This also reinforces the
need for multi-omics data to understand a complex disorder like alcoholism. eQTLs for genes in the brown4
module (N = 726 genes) were signiﬁcantly enriched for
GWAS signals (P = 4.2 × 10−3) in the PGC-AD GWAS.
Interestingly this module was also positively correlated
with alcohol dependence (0.18, P = 4.0 × 10−2) in traitmodule correlation analysis.
Because of limited availability of human post-mortem
tissue with DSM4 alcohol dependence phenotype, we
tried to look for validation in rodent RNA-expression
datasets (Supplementary methods; supplementary table
2). The hub genes identiﬁed in present analysis were
found to be signiﬁcant enriched for association signals in
the rodents. This observation adds to the validity of hub
genes in the identiﬁed modules.
In the present study, we focused on integrating the
genomic information to transcriptomic data to identify
gene (genetic background) × environment (alcohol exposure) interactions in the etiology of alcohol use disorders.
As mentioned in the discussion we identiﬁed that genes
that have altered expression due to alcohol exposure
interact with risk genes (GWAS) to increase an individual’s risk of becoming dependent on alcohol. So, to
translate these ﬁndings in animals, one has to mimic
expression of hub genes as well as the risk gene to alter
the pathways associated with alcoholism. We are also
reporting the direction of effect of the differential
expression. That should provide information that can be
used to see whether knock-down or overexpression of key
genes alters risk for AUD phenotypes in models. Also, the
replication of the modules in rodent models indicates
which models might be useful to study the effects of
dysregulation in these models.
Multiple lines of evidence derived from this study
allowed us to prioritize the genes altered by exposure to
alcohol. The gene co-expression network analysis also
identiﬁed networks of genes altered in alcohol-dependent
subjects. Further support for our ﬁndings comes from
work showing that many genes in these networks were
also associated with alcohol dependence and alcohol
consumption in large GWAS study cohorts. This systematic exploration of transcriptomic organization in the
PFC from alcoholics provides further support for the role
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of the neuroimmune system in alcohol dependence. The
biological pathways and networks of genes identiﬁed in
the current study will help prioritize genes for functional
studies and may help advance targeted treatment
approaches for alcohol use disorders.
Data availability
Data sharing policy: RNA-Seq data for alcohol dependence cases and controls
will be available through GEO. All the summary statistics for differential
expression will also be posted at INIA and COGA’s homepage (and Shiny web
app) and will be freely available to download after publication is online. Shiny
webapp link for entire summary statistics: https://lcad.shinyapps.io/coga-inia/
(Access code: coga-inia).
Acknowledgements
COGA: The Collaborative Study on the Genetics of Alcoholism (COGA),
Principal Investigators B.P., V.H., H.E., L.B., includes eleven different centers:
University of Connecticut (V. Hesselbrock); Indiana University (H.J.E., J.N.Jr., T.F.;
Y.L.); University of Iowa (S. Kuperman, J. Kramer); SUNY Downstate (B.P.);
Washington University in St. Louis (L. Bierut, J. Rice, K. Bucholz, A.A.); University
of California at San Diego (M. Schuckit); Rutgers University (J.T., A. Brooks);
Department of Biomedical and Health Informatics, The Children’s Hospital of
Philadelphia; Department of Genetics, Perelman School of Medicine, University
of Pennsylvania, Philadelphia PA (L. Almasy), Virginia Commonwealth
University (D. Dick), Icahn School of Medicine at Mount Sinai (A. Goate), and
Howard University (R. Taylor). Other COGA collaborators include: L. Bauer
(University of Connecticut); J. McClintick, L. Wetherill, X. Xuei, D. Lai, S.
O’Connor, M. Plawecki, S. Lourens (Indiana University); G. Chan (University of
Iowa; University of Connecticut); J. Meyers, D. Chorlian, C. Kamarajan, A. Pandey,
J. Zhang (SUNY Downstate); J.-C.W., M.K., S.B. (Icahn School of Medicine at
Mount Sinai); A. Anokhin, V. McCutcheon, S. Saccone (Washington University);
J. Salvatore, F. Aliev, B. Cho (Virginia Commonwealth University); and Mark Kos
(University of Texas Rio Grande Valley). A. Parsian and H. Chen are the NIAAA
Staff Collaborators. We continue to be inspired by our memories of Henri
Begleiter and Theodore Reich, founding PI and Co-PI of COGA, and also owe a
debt of gratitude to other past organizers of COGA, including Ting-Kai Li, P.
Michael Conneally, Raymond Crowe, and Wendy Reich, for their critical
contributions. This national collaborative study is supported by NIH Grant
U10AA008401 from the National Institute on Alcohol Abuse and Alcoholism
(NIAAA) and the National Institute on Drug Abuse (NIDA). We are also grateful
to the New South Wales Tissue Resource Centre at the University of Sydney for
providing human brain samples; the Centre is supported by the National
Health and Medical Research Council of Australia, Schizophrenia Research
Institute, and National Institute on Alcohol Abuse and Alcoholism (NIH/NIAAA
R24AA012725). Mayﬁeld grant support: U01 AA020926 and R01 AA012404.
Kapoor grant: R21AA026388. The work was also supported in part by the
Integrative Neuroscience Initiative on Alcoholism (INIA)-Neuroimmue
consortium (5U24AA025479-02).
Author details
1
Department of Neuroscience, Icahn School of Medicine at Mt. Sinai, 1425
Madison Ave, New York, NY, USA. 2The Waggoner Center for Alcohol and
Addiction Research, The University of Texas at Austin, Austin, TX 78712, USA.
3
Department of Medical and Molecular Genetics, Indiana University School of
Medicine, Indianapolis, IN, USA. 4Department of Biological Sciences, Indian
Institute of Science Education and Research, Bhopal, MP 462066, India.
5
Department of Psychiatry, Henri Begleiter Neurodynamics Lab, State
University of New York, Downstate Medical Center, Brooklyn, NY, USA.
6
Department of Genetics and the Human Genetics Institute of New Jersey,
Rutgers University, Piscataway, NJ, USA. 7Department of Psychiatry,
Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
8
Department of Psychiatry, University of Connecticut, Farmington, CT, USA
Competing interests
A.G. and J.-C.W. are listed as inventors on Issued U.S. Patent 8080,371, “Markers
for Addiction” covering the use of certain variants in determining the
diagnosis, prognosis, and treatment of addiction. The other authors declare no
competing interests.

Page 10 of 11 89

Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Supplementary Information accompanies this paper at (https://doi.org/
10.1038/s41398-019-0384-y).
Received: 6 December 2018 Accepted: 2 January 2019

References
1. Bell, C. C. DSM-IV: diagnostic and statistical manual of mental disorders. JAMA
272, 828–829 (1994).
2. Sacks, J. J., Gonzales, K. R., Bouchery, E. E., Tomedi, L. E. & Brewer, R. D. 2010
National and State costs of excessive alcohol consumption. Am. J. Prev. Med.
49, e73–e79 (2015).
3. Contet, C. Gene expression under the inﬂuence: transcriptional proﬁling of
ethanol in thebrain. Curr. Psychopharmacol. 1, 301–314 (2012).
4. Alfonso-Loeches, S. & Guerri, C. Molecular and behavioral aspects of the
actions of alcohol on the adult and developing brain. Crit. Rev. Clin. Lab. Sci. 48,
19–47 (2011).
5. Fan, L. et al. Increased expression of mitochondrial genes in human
alcoholic brain revealed by differential display. Alcohol. Clin. Exp. Res. 23,
408–413 (1999).
6. Mayﬁeld, R. D., Harris, R. A. & Schuckit, M. A. Genetic factors inﬂuencing alcohol
dependence. Br. J. Pharmacol. 154, 275–287 (2008).
7. McClintick, J. N. et al. Stress-response pathways are altered in the hippocampus of chronic. Alcohol. Alcohol Fayettev. N. 47, 505–515 (2013).
8. Mamdani, M. et al. Integrating mRNA and miRNA weighted gene coexpression networks with eqtls in the nucleus accumbens of subjects with
alcohol dependence. PLoS ONE 10, e0137671 (2015).
9. Farris, S. P., Arasappan, D., Hunicke-Smith, S., Harris, R. A. & Mayﬁeld, R. D.
Transcriptome organization for chronic alcohol abuse in human brain. Mol.
Psychiatry 20, 1438–1447 (2015).
10. Oldham, M. C. et al. Functional organization of the transcriptome in human
brain. Nat. Neurosci. 11, 1271–1282 (2008).
11. Flatscher-Bader, T. & Wilce, P. A. Chronic smoking and alcoholism change
expression of selective genes in the human prefrontal cortex. Alcohol. Clin. Exp.
Res. 30, 908–915 (2006).
12. Mayﬁeld, J., Ferguson, L. & Harris, R. A. Neuroimmune signaling: a key component of alcohol abuse. Curr. Opin. Neurobiol. 23, 513–520 (2013).
13. Farris, S. P. & Mayﬁeld, R. D. RNA-Seq reveals novel transcriptional reorganization in human alcoholic brain. Int. Rev. Neurobiol. 116, 275–300 (2014).
14. Hermann, D. et al. Low μ-opioid receptor status in alcohol dependence
identiﬁed by combined positron emission tomography and post-mortem
brainanalysis. Neuropsychopharmacology 42, 606–614 (2017).
15. Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation
network analysis. BMC Bioinforma. 9, 559 (2008).
16. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29,
15–21 (2013).
17. Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efﬁcient general purpose
program for assigning sequence reads to genomic features. Bioinforma. Oxf.
Engl. 30, 923–930 (2014).
18. Hoffman, G. E. & Schadt, E. E. variancePartition: interpreting drivers of variation
in complex gene expression studies. BMC Bioinforma. 17, 483 (2016).
19. Love, M. I., Huber, W., Anders, S. Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2. Genome Biol. 15. https://doi.org/
10.1186/s13059-014-0550-8 (2014).
20. Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProﬁler: an R package for comparing biological themes among gene clusters. OMICS J. Integr. Biol. 16,
284–287 (2012).
21. Li, Z. et al. Genetic variants associated with Alzheimer’s disease confer different
cerebral cortex cell-type population structure. Genome Med. 10, 43 (2018).
22. Walters, R. K. et al. Trans-ancestral GWAS of alcohol dependence reveals
common genetic underpinnings with psychiatric disorders. Nat. Neurosci. 21,
1656–1669 (2018).
23. Clarke, T.-K. et al. Genome-wide association study of alcohol consumption and
genetic overlap with other health-related traits in UK Biobank (N=112 117).
Mol. Psychiatry 22, 1376–1384 (2017).

Kapoor et al. Translational Psychiatry (2019)9:89

24. Tobacco and Genetics Consortium. Genome-wide meta-analyses identify
multiple loci associated with smoking behavior. Nat. Genet. 42, 441–447
(2010).
25. Bennett, D. A. et al. Overview and ﬁndings from the rush Memory and Aging
Project. Curr. Alzheimer Res. 9, 646–663 (2012).
26. de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized
gene-set analysis of GWAS data. PLoS Comput. Biol. 11, https://doi.org/
10.1371/journal.pcbi.1004219 (2015).
27. Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional
mapping and annotation of genetic associations with FUMA. Nat. Commun. 8,
1826 (2017).
28. Kerns, R. T. et al. Ethanol-responsive brain region expression networks: implications for behavioral responses to acute ethanol in DBA/2J versus C57BL/6J
Mice. J. Neurosci. 25, 2255–2266 (2005).
29. Treadwell, J. A. & Singh, S. M. Microarray analysis of mouse brain gene
expression following acute ethanol treatment. Neurochem. Res. 29, 357–369
(2004).
30. Qiu, B. et al. The FKBP5 gene affects alcohol drinking in knockout mice and is
implicated in alcohol drinking in humans. Int. J. Mol. Sci. 17. https://doi.org/
10.3390/ijms17081271 (2016).
31. Nylander, I. et al. Evidence for a link between Fkbp5/FKBP5, early life social
relations and alcohol drinking in young adult rats and humans. Mol. Neurobiol.
54, 6225–6234 (2017).
32. Xie, P. et al. Interaction of FKBP5 with childhood adversity on risk for posttraumatic stress disorder. Neuropsychopharmacol. Publ. Am. Coll. Neuropsychopharmacol. 35, 1684–1692 (2010).
33. Huang, M.-C. et al. FKBP5 moderates alcohol withdrawal severity: human
genetic association and functional validation in knockout mice. Neuropsychopharmacology 39, 2029–2038 (2014).

Page 11 of 11 89

34. Platanias, L. C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375–386 (2005).
35. Crews, F. T., Zou, J. & Qin, L. Induction of innate immune genes in brain create
the neurobiology of addiction. Brain Behav. Immun. 25, S4–S12 (2011).
36. Kalinin, S. et al. Transcriptome analysis of alcohol-treated microglia reveals
downregulation of beta amyloid phagocytosis. J. Neuroinﬂamm. 15, 141
(2018).
37. Fromer, M. et al. Gene expression elucidates functional impact of polygenic
risk for schizophrenia. Nat. Neurosci. 19, 1442–1453 (2016).
38. Agrawal, A. & Bierut, L. J. Identifying genetic variation for alcohol dependence.
Alcohol Res Curr. Rev. 34, 274–281 (2012).
39. Edenberg, H. J. & Foroud, T. The genetics of alcoholism: identifying speciﬁc
genes through family studies. Addict. Biol. 11, 386–396 (2006).
40. Gelernter, J. et al. Genome-wide association study of alcohol dependence:
signiﬁcant ﬁndings in African- and European-Americans including novel risk
loci. Mol. Psychiatry 19, 41–49 (2014).
41. Kapoor, M. et al. Genome-wide polygenic scores for age at onset of alcohol
dependence and association with alcohol-related measures. Transl. Psychiatry
6, e761 (2016).
42. Netzeband, J. G. & Gruol, D. L. Modulatory effects of acute ethanol on
metabotropic glutamate responses in cultured Purkinje neurons. Brain Res.
688, 105–113 (1995).
43. Mullikin-Kilpatrick, D., Mehta, N. D., Hildebrandt, J. D. & Treistman, S. N. Gi is
involved in ethanol inhibition of L-type calcium channels in undifferentiated but not differentiated PC-12 cells. Mol. Pharmacol. 47, 997–1005
(1995).
44. Warden, A., Erickson, E., Robinson, G., Harris, R. A. & Mayﬁeld, R. D. The neuroimmune transcriptome and alcohol dependence: potential for targeted
therapies. Pharmacogenomics 17, 2081–2096 (2016).

